Hot Life Science Investor Mandate 3: Taiwan-Based Firm Seeks Therapeutic Opportunities In US, EU, Canada

17 Sep

A venture capital firm founded in 1988 and headquartered in Taipei, Taiwan is currently investing from its fourth fund of US$27 million that was closed in 2013. Traditionally the firm has been focused on Taiwan-based assets but is now seeking new opportunities from North America and the EU.

Within life sciences, the firm is interested in therapeutics including small molecules, biologics, cell therapy, and gene therapy. The firm is agnostic in terms of indications. The firm prefers early stage assets that have obtained proof-of-concept data in animal models or clinical trials. The firm also considers healthcare services such as hospice and hemodialysis centers.

The firm is looking for competent management teams with sector expertise. After investment, the firm seeks to play an active role in Taiwan-based businesses or to take minority stake in overseas businesses.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: